Abstract:Objective
Anaemia is common during pregnancy, and prenatal Fe supplementation is the standard of care. However, the persistence of anaemia despite Fe supplementation, particularly in HIV infection, suggests that its aetiology may be more complex and warrants further investigation. The present study was conducted to examine predictors of incident haematological outcomes in HIV-infected pregnant women in Tanzania.
Design
Prospective cohort study. Cox proportional hazards and binomial regression models were use… Show more
“…12,13 In a study in Tanzania, low CD4 T-cell count, high erythrocyte sedimentation rate, and vitamin D insufficiency were noted as main predictors of anemia in HIV-infected pregnant and postpartum women. 14 Patients who were being treated for TB were at higher risk for anemia. Previous studies have shown that anemia, along with other factors such as HIV disease progression and CD4 ALT = alanine aminotransferase; ART = antiretroviral treatment; AZT = zidovudine; BMI = body mass index; CI = confidence interval; D4T = stavudine; EFV = efavirenz; TDF = tenofovir; FTC = emtricitabine; Hgb = hemoglobin; HIV = human immunodeficiency virus; IDA = iron deficiency anemia; MCV = mean corpuscular volume; NVP = nevirapine; TB = tuberculosis; 3TC = lamivudine; WHO = World Health Organization.…”
Anemia is often a comorbidity of human immunodeficiency virus (HIV) infection. Many cross-sectional studies have been conducted on anemia and HIV, but few, if any, have addressed incidence of anemia prospectively. A longitudinal analysis was conducted in 48,068 nonpregnant HIV-infected adults in Dar es Salaam, Tanzania, seen at Management and Development for Health–U.S. President's Emergency Plan for AIDS Relief HIV care and treatment programs between 2004 and 2011. Almost 56% (N = 27,184) of study participants had anemia (hemoglobin < 11 g/dL) at the time of enrollment at the clinic. Female gender, low body mass index (BMI), low CD4 T-cell count, high levels of liver enzyme alanine aminotransferase, antiretroviral treatment (ART) regimens, and concurrent tuberculosis treatment were all independently significantly associated with an increased risk of anemia. Low BMI and low CD4 T-cell count were independently significantly associated with an increased risk for iron deficiency anemia (IDA). Higher BMI status and ART use were associated with recovery from anemia. Anemia, including IDA, is a comorbidity that is associated with other adverse consequences (e.g., low BMI and CD4 T-cell count) among individuals with HIV infection, including those on ART. Interventions to prevent anemia and its complications need to be examined in the context of future studies.
“…12,13 In a study in Tanzania, low CD4 T-cell count, high erythrocyte sedimentation rate, and vitamin D insufficiency were noted as main predictors of anemia in HIV-infected pregnant and postpartum women. 14 Patients who were being treated for TB were at higher risk for anemia. Previous studies have shown that anemia, along with other factors such as HIV disease progression and CD4 ALT = alanine aminotransferase; ART = antiretroviral treatment; AZT = zidovudine; BMI = body mass index; CI = confidence interval; D4T = stavudine; EFV = efavirenz; TDF = tenofovir; FTC = emtricitabine; Hgb = hemoglobin; HIV = human immunodeficiency virus; IDA = iron deficiency anemia; MCV = mean corpuscular volume; NVP = nevirapine; TB = tuberculosis; 3TC = lamivudine; WHO = World Health Organization.…”
Anemia is often a comorbidity of human immunodeficiency virus (HIV) infection. Many cross-sectional studies have been conducted on anemia and HIV, but few, if any, have addressed incidence of anemia prospectively. A longitudinal analysis was conducted in 48,068 nonpregnant HIV-infected adults in Dar es Salaam, Tanzania, seen at Management and Development for Health–U.S. President's Emergency Plan for AIDS Relief HIV care and treatment programs between 2004 and 2011. Almost 56% (N = 27,184) of study participants had anemia (hemoglobin < 11 g/dL) at the time of enrollment at the clinic. Female gender, low body mass index (BMI), low CD4 T-cell count, high levels of liver enzyme alanine aminotransferase, antiretroviral treatment (ART) regimens, and concurrent tuberculosis treatment were all independently significantly associated with an increased risk of anemia. Low BMI and low CD4 T-cell count were independently significantly associated with an increased risk for iron deficiency anemia (IDA). Higher BMI status and ART use were associated with recovery from anemia. Anemia, including IDA, is a comorbidity that is associated with other adverse consequences (e.g., low BMI and CD4 T-cell count) among individuals with HIV infection, including those on ART. Interventions to prevent anemia and its complications need to be examined in the context of future studies.
“…Hemoglobin was categorized as 11 g/dL (normal), 8.5 and 11 g/dL (anemic), and 8.5 g/dL (severely anemic). [16][17][18] In bivariate analyses, we compared the distribution of the continuous SOFA score outcome between categories of each predictor using the Kruskall Wallis test. Adjusted mean differences and 95% confidence intervals (CIs) for the continuous SOFA score outcome were estimated from multivariable linear regression using empirical variances.…”
Abstract. Risk factors for progression from acute malaria to multiple organ dysfunction syndrome (MODS) are poorly understood. The MODS is commonly diagnosed with the sequential organ failure assessment (SOFA) scale, but this scale has been understudied in patients with severe malaria. We conducted a cohort study among 426 adult males admitted to hospital with malaria in Bogotá, Colombia. We estimated SOFA scores and relative risks (RRs) for MODS during hospitalization according to patients' characteristics on admission. Risk of MODS was 7.3% over a median 6.0 days in hospital. Baseline hemoglobin was strongly, inversely associated with MODS (adjusted RR for hemoglobin 8.5 g/dL versus hemoglobin 11 g/dL = 9.5, 95% confidence interval [CI]: 3.6, 25.3). Plasmodium falciparum malaria and parasitemia were positively associated with MODS. There was a strong interaction between baseline parasitemia and hemoglobin on MODS risk. In conclusion, the use of parasitemia and hemoglobin on admission to identify high-risk patients deserves consideration.
“…The authors reported that 'micronutrient supplementation and infectious disease control, is warranted in HIV-infected women in resource-limited settings' (1) . I agree completely with this useful suggestion.…”
Section: Madammentioning
confidence: 99%
“…In addition to Hb concentrations, serum ferritin and transferrin receptor, and at least one acute-phase protein, such as C-reactive protein or a-1 acid glycoprotein, would further improve Fe assessment in the context of inflammation and infection. With an average of nine Hb measurements per person (over 9000) collected prospectively at the time of the study, it was not possible to conduct a more detailed analysis of Fe status on all samples collected prospectively in the ancillary analysis (1) . However, we previously published a detailed analysis of Fe status in the same cohort to examine the proportion of anaemia attributable to Fe deficiency among 584 HIV-infected women, including Hb, serum ferritin, serum transferrin receptor and C-reactive protein concentrations (7) .…”
Letters to the Editor HIV and iron-deficiency anaemia Predictors of HIV and iron-deficiency anaemia: a comment Madam I read the recent article on HIV and Fe-deficiency anaemia by Finkelstein et al., published online in your journal, with great interest (1). The authors reported that 'micronutrient supplementation and infectious disease control, is warranted in HIV-infected women in resource-limited settings' (1). I agree completely with this useful suggestion. Indeed, the prevalence of both HIV and anaemia is still high in developing countries and these two diseases need focus in antenatal care (2). However, some facts should be noted. First, in a recent publication it is mentioned that HIV does not increase the risk of anaemia among the pregnant (2). This report might be discordant with Finkelstein et al.'s finding that immunity, specifically CD4 T-cell count, can take a role. The explanation might lie in the different settings and numbers of subjects. Second, in Finkelstein et al.'s work, although the authors tried to study several parameters, there might be some pitfalls. The quality control of the determination of Hb should be discussed. Also, there is no proof for Fe-deficiency anaemia by Fe status in the study subjects. It should be noted that a similar picture, i.e. presentation of anaemia with hypochromic microcytic blood, can be seen in cases with congenital Hb disorder such as thalassaemia and this can be a confounding factor that was not well controlled for in Finkelstein et al.'s work.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.